Chapter 33/34: Purines and Pyrimidines metabolism II/III Flashcards
In the salvage pathway for purine synthesis, _______ + _________ yields IMP and PPi via the enzyme ____________.
- hypoxanthine
- PRPP
- hypoxanthine-guanine phosphorybosyltransferase (HGPRT)
In the salvage pathway for purine synthesis, _______ + _________ yields GMP and PPi via the enzyme ____________.
- Guanine
- PRPP
- Hypoxanthine-guanine phosphorybosyltransferase (HGPRT)
In the salvage pathway for purine synthesis, _______ + _________ yields AMP and PPi via the enzyme ____________. AMP can also be synthesized indirectly (MORE COMMON) from _____ (hypoxanthine + PRPP).
- Adenine
- PRPP
- Adenine phosphorybosyltransferase (APRT)
- IMP (instead of free adenine)
Hypoxanthine-guanine phosphorybosyltransferase (HGPRT) is inhibited by what?
its products IMP and GMP (feedback inhibition)
In purine degradation, ____% is recycled by salvage enzymes and only ____% is converted to _________ and excreted.
- 90%
- 10%
- Uric acid
Degradation first converts purines and purine nucleotides to __________. This is then converted via __________ to xanthine and ultimately to _________, which is excreted by the kidneys or GI tract
- hypoxanthine
- xanthine oxidase (converts BOTH hypoxanthine –> xanthine –> uric acid)
- uric acid
IMP/AMP degradation:
1st step: The **hydrolytic removal of phosphate (nucleotides –> nucleosides) from AMP or IMP via ______________. AMP forms _______ and IMP forms _______.
2nd step: Adenosine is converted to inosine by ___________, which removes an amino group.
3rd step: __________ is removed from inosine via Purine nucleoside phosphorylase (PNP). This reaction yields _________.
4th: hypoxanthine can then be converted to xanthine and then uric acid via _______.
- ***nucleotidases, adenosine, inosine
- adenosine deaminase (ADA)
- ribose (*as ribose-1-P), hypoxantine
- xanthine oxidase
GMP degradation:
1st step: The **hydrolytic removal of phosphate (nucleotides –> nucleosides) from GMP via ______________ to form _______.
2nd step: __________ is removed from guanosine via Purine nucleoside phosphorylase (PNP). This reaction yields _________.
***3rd step: _________ removes an amino group from guanine to form xanthine. Xanthine can then be converted into uric acid for excretion.
- nucleotidases, guanosine
- ribose (as R-1-P), guanine
- *Guanine deaminase (or guanase)
Important enzymes in AMP, GMP and IMP degradation
Nucleotidases: nucleotide (AMP, GMP, IMP) –> nucleoside (adenosine, guanosine, inosine)
Purine nucleoside phosphorylase (PNP): removes ribose as R-1-P to form hypoxanthine (AMP/IMP) or guanine (GMP)
Xanthine oxidase: converts hypoxanthine –> xanthine (AMP/IMP) and xanthine –> uric acid (ALL)
The ________ pathway in purine metabolism leads to more ATP and GTP production whereas the _______ pathway generates more purine breakdown products. High de novo activity increases purine turnover, resulting in higher _________ concentrations. Higher salvage pathway activity leads to decreased __________ and reduces plasma uric acid. An increase in the salvage pathway depletes _______ levels.
- salvage
- de novo
- plasma uric acid
- de novo synthesis
- PRPP
What disease is caused by increased plasma uric acid levels (hyperuricemia)? What forms and what areas are most affected?
dx: GOUT
product: Uric acid crystals can form (can form kidney stones)
affected areas: **joints and kidney tubules (slow blood flow, synovial fluid favors the precipitate), ***big toe (higher gravitational pull)
Rapid inflammation of the joints (usually the big toe, can affect other joints too) due to hyperuricemia is called ________? Repeated instances can lead to ________? The inflammation is caused by ____________.
- A gouty attack, VERY painful (HOT, red, swollen/tender joints)
- arthritis
- leukocytes
What dx results from any of the following:
- Increased uric acid due to increased NUCLEIC ACID turnover. Causes?***
- Increased uric acid due to increased ATP degradation. Causes?
- Accelerated ATP catabolism and decreased renal excretion of uric acid. Causes?
- Increased tubular reabsorption of uric acid. Causes?
SECONDARY GOUT
- causes: leukemias, lymphomas, and after chemotherapy.**
- causes: glycogen storage diseases and tissue hypoxia.
- causes: Ethanol intake or primary renal dx
- causes: dehydration and diuretics
Lead exposure can lead to ___________. This causes lead nephropathy.
Saturnine gout
History:
1. prevalent in 18th-century England among the upper classes due to lead plumbing
2. prevalent with the romans because they drank from vessels containing lead
Causes of hyperuricemia?
- Effect of any of the following? Idiopathic, renal failure, Medication, Dehydration, Alcohol consumption, Obesity/diabetes, High fructose corn syrup, Chemotherapy/radiation
- Effect of any of the following? increased purine degradation, Consumption of purine-rich foods (animal origin)
- Effect of the following? Von Gierke disease
- Underexcretion of uric acid by the kidneys
- Overproduction of purines
- Glycogen storage dx: can’t break down glycogen = lactic acidosis. Lactic acid competes for excretion with uric acid, causes a build- up of uric acid.
When treating gout, your doctor recommends a low-purine diet. Which of the following should you avoid?
A. Sugary foods/beverages with high fructose corn syrup.
B. Fruits and vegetables, especially apples
C. Seafood
D. Meat, especially liver and game meats.
E. Black coffee and tea
F. Alcoholic beverages, especially beer
A, C, D, F
What medicine can be used for the treatment of gout? What is its effect?
Allopurinol: it inhibits xanthine oxidase, stopping the rxn of
hypoxanthine to xanthine and ultimately to uric acid
**stops uric acid formation
Higher levels of hypoxanthine does NOT have a negative effect –>
it gets recycled back to the purine salvage pathway by HGPRT!
**What X-linked dx is caused by polymorphisms (defects) in HGPRT, resulting in increased levels of PRPP and decreased nucleotide production? What is the result?
Dx: Lesch-Nyhan syndrome
Increased PRPP: Self- mutilation, Mental retardation, Hyperuricemia
Decreased nucleotide production: decreased dopamine production, lesions in striatal dopaminergic pathways
**What autosomal recessive metabolic disorder is caused by a deficiency in adenosine deaminase? What is the effect?
disorder: Severe combined immunodeficiency disease (SCID)
effect: Primary immunodeficiency, lack of both B-cell and T-cell function = increased infections (bacterial, viral and fungal)
What is required for pyrimidine biosynthesis? Where does it take place?
Required: Glutamine, HCO3- (bicarbonate), H2O, ATP (x2)
Ammonia (NH3) is derived from Gln hydrolysis
Location: Liver (because it can handle the ammonia waste)
First step in de novo pyrimidine synthesis requires what enzyme?
2 ATP + HCO3- + NH3 –> carbamoyl phosphate + 2 ADP + Pi
enzyme: carbamoyl phosphate synthetase II (CPS II)
activators and inhibitors of carbamoyl phosphate synthetase (CPS II)?
activated by: PRPP, ATP, glutamine
inhibited by: UMP, UDP, UTP (end products)
Once carbamoyl phosphate is formed, _____ is added via _____________ to make carbamoyl aspartate. After a couple of reactions, the enzyme dihydroorotase makes ________, which has the basic pyrimidine ring shape.
- aspartate
- aspartate transcarbamoylase (ATCase)
- Orotate
Activators (turns ON pyrimidine production) and inhibitors (turns OFF pyrimidine production) of aspartate transcarbamoylase (ATCase)?
activated by: Aspartate (substrate) = ON
inhibited by: Cytidine triphosphate (CTP) = OFF